| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |